Literature DB >> 23974195

Mixed hematopoietic or T-cell chimerism above a minimal threshold restores perforin-dependent immune regulation in perforin-deficient mice.

Catherine E Terrell1, Michael B Jordan.   

Abstract

Defects in perforin and related genes lead to a loss of normal immune regulation and underlie hemophagocytic lymphohistiocytosis (HLH), which requires hematopoietic cell transplantation for long-term cure. However, transplantation may be complicated by the development of mixed chimerism and uncertainty regarding the risk of HLH recurrence. To help clarify this risk and investigate how perforin influences immune activation, we studied perforin-mediated immune regulation in the context of mixed chimerism using a murine model of HLH. We found that there is a distinct threshold of ∼10% to 20% perforin expression with either mixed hematopoietic or CD8(+) T cell chimerism, above which immune regulation was reestablished. These findings demonstrate that perforin-mediated immunoregulation functions in trans and are consistent with a feedback model in which cytotoxic T cells control immune activation by killing dendritic cells. These findings also suggest rational targets for maintenance of minimal posttransplant chimerism and for therapeutic strategies involving gene correction.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23974195      PMCID: PMC3795460          DOI: 10.1182/blood-2013-06-508143

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  17 in total

1.  Perforin is a critical physiologic regulator of T-cell activation.

Authors:  Jennifer E Lykens; Catherine E Terrell; Erin E Zoller; Kimberly Risma; Michael B Jordan
Journal:  Blood       Date:  2011-05-23       Impact factor: 22.113

2.  Stem cell transplantation with reduced-intensity conditioning for hemophagocytic lymphohistiocytosis.

Authors:  Nichola Cooper; Kanchan Rao; Kimberly Gilmour; Lema Hadad; Stuart Adams; Cathy Cale; Graham Davies; David Webb; Paul Veys; Persis Amrolia
Journal:  Blood       Date:  2005-10-11       Impact factor: 22.113

3.  Disruption of MyD88 signaling suppresses hemophagocytic lymphohistiocytosis in mice.

Authors:  Philippe Krebs; Karine Crozat; Daniel Popkin; Michael B Oldstone; Bruce Beutler
Journal:  Blood       Date:  2011-05-06       Impact factor: 22.113

4.  Reduced-intensity conditioning significantly improves survival of patients with hemophagocytic lymphohistiocytosis undergoing allogeneic hematopoietic cell transplantation.

Authors:  Rebecca A Marsh; Gretchen Vaughn; Mi-Ok Kim; Dandan Li; Sonata Jodele; Sarita Joshi; Parinda A Mehta; Stella M Davies; Michael B Jordan; Jack J Bleesing; Alexandra H Filipovich
Journal:  Blood       Date:  2010-09-20       Impact factor: 22.113

5.  Unrelated donor hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis.

Authors:  K S Baker; A H Filipovich; T G Gross; W J Grossman; G A Hale; R J Hayashi; N R Kamani; S Kurian; N Kapoor; O Ringdén; M Eapen
Journal:  Bone Marrow Transplant       Date:  2008-05-05       Impact factor: 5.483

6.  Hematopoietic stem cell transplantation in hemophagocytic lymphohistiocytosis: a single-center report of 48 patients.

Authors:  Marie Ouachée-Chardin; Caroline Elie; Geneviève de Saint Basile; Françoise Le Deist; Nizar Mahlaoui; Capucine Picard; Bénédicte Neven; Jean-Laurent Casanova; Marc Tardieu; Marina Cavazzana-Calvo; Stéphane Blanche; Alain Fischer
Journal:  Pediatrics       Date:  2006-03-20       Impact factor: 7.124

7.  An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder.

Authors:  Michael B Jordan; David Hildeman; John Kappler; Philippa Marrack
Journal:  Blood       Date:  2004-04-06       Impact factor: 22.113

Review 8.  The use of reduced-intensity stem cell transplantation in haemophagocytic lymphohistiocytosis and Langerhans cell histiocytosis.

Authors:  N Cooper; K Rao; N Goulden; D Webb; P Amrolia; P Veys
Journal:  Bone Marrow Transplant       Date:  2008-10       Impact factor: 5.483

9.  Perforin deficiency impairs a critical immunoregulatory loop involving murine CD8(+) T cells and dendritic cells.

Authors:  Catherine E Terrell; Michael B Jordan
Journal:  Blood       Date:  2013-05-09       Impact factor: 22.113

10.  Neutralization of IFNgamma defeats haemophagocytosis in LCMV-infected perforin- and Rab27a-deficient mice.

Authors:  Jana Pachlopnik Schmid; Chen-H Ho; Fabrice Chrétien; Juliette M Lefebvre; Gérard Pivert; Marie Kosco-Vilbois; Walter Ferlin; Frédéric Geissmann; Alain Fischer; Geneviève de Saint Basile
Journal:  EMBO Mol Med       Date:  2009-05       Impact factor: 12.137

View more
  19 in total

1.  Functional and genetic testing in adults with HLH reveals an inflammatory profile rather than a cytotoxicity defect.

Authors:  Julien Carvelli; Christelle Piperoglou; Catherine Farnarier; Frédéric Vely; Karin Mazodier; Sandra Audonnet; Patrick Nitschke; Christine Bole-Feysot; Mohamed Boucekine; Audrey Cambon; Mohamed Hamidou; Jean-Robert Harle; Geneviève de Saint Basile; Gilles Kaplanski
Journal:  Blood       Date:  2020-07-30       Impact factor: 22.113

2.  Haematopoietic stem cell transplantation for refractory Langerhans cell histiocytosis: outcome by intensity of conditioning.

Authors:  Paul A Veys; Vasanta Nanduri; K Scott Baker; Wensheng He; Giuseppe Bandini; Andrea Biondi; Arnaud Dalissier; Jeffrey H Davis; Gretchen M Eames; R Maarten Egeler; Alexandra H Filipovich; Alain Fischer; Herbert Jürgens; Robert Krance; Edoardo Lanino; Wing H Leung; Susanne Matthes; Gérard Michel; Paul J Orchard; Anna Pieczonka; Olle Ringdén; Paul G Schlegel; Anne Sirvent; Kim Vettenranta; Mary Eapen
Journal:  Br J Haematol       Date:  2015-03-27       Impact factor: 6.998

3.  High Level of Perforin Expression Is Required for Effective Correction of Hemophagocytic Lymphohistiocytosis.

Authors:  Swati Tiwari; Adrianne Hontz; Catherine E Terrell; Paritha Arumugam; Marlene Carmo; Kimberly Risma; Michael Jordan; Punam Malik
Journal:  Hum Gene Ther       Date:  2016-07-29       Impact factor: 5.695

4.  Targeted busulfan-based reduced-intensity conditioning and HLA-matched HSCT cure hemophagocytic lymphohistiocytosis.

Authors:  Matthias Felber; Colin G Steward; Karim Kentouche; Anders Fasth; Robert F Wynn; Ulrike Zeilhofer; Veronika Haunerdinger; Benjamin Volkmer; Seraina Prader; Bernd Gruhn; Stephan Ehl; Kai Lehmberg; Daniel Müller; Andrew R Gennery; Michael H Albert; Fabian Hauck; Kanchan Rao; Paul Veys; Moustapha Hassan; Arjan C Lankester; Jana Pachlopnik Schmid; Mathias M Hauri-Hohl; Tayfun Güngör
Journal:  Blood Adv       Date:  2020-05-12

5.  Lentiviral Gene Therapy for Familial Hemophagocytic Lymphohistiocytosis Type 3, Caused by UNC13D Genetic Defects.

Authors:  Sarah E Takushi; Na Yoon Paik; Andrew Fedanov; Chengyu Prince; Christopher B Doering; H Trent Spencer; Shanmuganathan Chandrakasan
Journal:  Hum Gene Ther       Date:  2020-06       Impact factor: 5.695

Review 6.  Genetic defects in cytolysis in macrophage activation syndrome.

Authors:  Mingce Zhang; Edward M Behrens; T Prescott Atkinson; Bita Shakoory; Alexei A Grom; Randy Q Cron
Journal:  Curr Rheumatol Rep       Date:  2014       Impact factor: 4.592

7.  The minimum required level of donor chimerism in hereditary hemophagocytic lymphohistiocytosis.

Authors:  Bernd Hartz; Rebecca Marsh; Kanchan Rao; Jan-Inge Henter; Michael Jordan; Lisa Filipovich; Peter Bader; Rita Beier; Birgit Burkhardt; Roland Meisel; Ansgar Schulz; Beate Winkler; Michael H Albert; Johann Greil; Gülsün Karasu; Wilhelm Woessmann; Selim Corbacioglu; Bernd Gruhn; Wolfgang Holter; Jörn-Sven Kühl; Peter Lang; Markus G Seidel; Paul Veys; Alexandra Löfstedt; Sandra Ammann; Stephan Ehl; Gritta Janka; Ingo Müller; Kai Lehmberg
Journal:  Blood       Date:  2016-04-20       Impact factor: 22.113

8.  T-cell activation profiles distinguish hemophagocytic lymphohistiocytosis and early sepsis.

Authors:  Vandana Chaturvedi; Rebecca A Marsh; Adi Zoref-Lorenz; Erika Owsley; Vijaya Chaturvedi; Trung C Nguyen; Jordana R Goldman; Michael M Henry; Jay N Greenberg; Stephan Ladisch; Michelle L Hermiston; Michael Jeng; Ahmed Naqvi; Carl E Allen; Hector R Wong; Michael B Jordan
Journal:  Blood       Date:  2021-04-29       Impact factor: 25.476

Review 9.  Challenges in the diagnosis of hemophagocytic lymphohistiocytosis: Recommendations from the North American Consortium for Histiocytosis (NACHO).

Authors:  Michael B Jordan; Carl E Allen; Jay Greenberg; Michael Henry; Michelle L Hermiston; Ashish Kumar; Melissa Hines; Olive Eckstein; Stephan Ladisch; Kim E Nichols; Carlos Rodriguez-Galindo; Birte Wistinghausen; Kenneth L McClain
Journal:  Pediatr Blood Cancer       Date:  2019-07-24       Impact factor: 3.167

Review 10.  Hemophagocytic lymphohistiocytosis: an update for nephrologists.

Authors:  Edward J Filippone; John L Farber
Journal:  Int Urol Nephrol       Date:  2016-04-20       Impact factor: 2.266

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.